Vo Elaine, Palacio Carlos H, Omino Ronald, Link Richard E, Sada Yvonne, Avo Artinyan
Baylor College of Medicine, Michael E. DeBakey Department of Surgery, United States.
Baylor College of Medicine, Margaret M. and Albert B. Alkek Department of Medicine, United States.
Int J Surg Case Rep. 2016;27:55-58. doi: 10.1016/j.ijscr.2016.07.053. Epub 2016 Aug 3.
Renal cell carcinoma (RCC) is the most common renal malignancy in adults. Metastatic disease is relatively common at presentation and frequently involves the lung, bone, brain, liver and adrenal glands. After curative resection, there is a 30-40% risk of recurrence, and a 10% risk of developing metastatic disease after 5 years. The gastrointestinal tract, particularly the colon, represents a very uncommon site of late metastatic disease.
We present a case of a 67 year-old-male who underwent a left radical nephrectomy for RCC 9 years before presenting with a metastatic large bowel obstruction. He was later found to have a near-completely obstructing mass in the rectosigmoid colon and underwent a sigmoidectomy with anterior resection of the upper rectum. Histopathology confirmed metastatic RCC confined to the colonic wall with negative microscopic margins.
The tendency of RCC to metastasize to unusual sites such as the pancreas or thyroid gland has been widely reported. However, cases of colon metastasis from RCC are extremely rare. Despite the absence of randomized prospective data, widespread consensus supports the surgical treatment of solitary and oligometastatic disease in light of the poor patient outcomes in non-surgically treated disease (Milovic et al., 2013) [3]. Multiple groups have reported favorable outcomes for surgically resected solitary metastatic disease with long disease-free intervals and good performance status.
The colon is a potential, though uncommon, site for solitary metastasis from RCC. The clinical presentation is frequently several years after initial curative resection. Oncologic resection with negative margins may result in long-term survival in patients with isolated metastatic disease.
肾细胞癌(RCC)是成人中最常见的肾脏恶性肿瘤。转移性疾病在就诊时相对常见,常累及肺、骨、脑、肝和肾上腺。根治性切除术后,复发风险为30%-40%,5年后发生转移性疾病的风险为10%。胃肠道,尤其是结肠,是晚期转移性疾病非常罕见的部位。
我们报告一例67岁男性,9年前因肾细胞癌接受了左肾根治性切除术,之后出现转移性大肠梗阻。后来发现他在直肠乙状结肠有一个几乎完全阻塞的肿块,并接受了乙状结肠切除术及上段直肠前切除术。组织病理学证实转移性肾细胞癌局限于结肠壁,显微镜下切缘阴性。
肾细胞癌转移至胰腺或甲状腺等不寻常部位的倾向已被广泛报道。然而,肾细胞癌转移至结肠的病例极为罕见。尽管缺乏随机前瞻性数据,但鉴于非手术治疗患者的不良预后,广泛的共识支持对孤立性和寡转移性疾病进行手术治疗(米洛维奇等人,2013年)[3]。多个研究小组报告了手术切除孤立性转移性疾病的良好结果,无病生存期长且功能状态良好。
结肠是肾细胞癌孤立转移的一个潜在部位,尽管并不常见。临床表现通常在初次根治性切除术后数年出现。切缘阴性的肿瘤切除可能会使孤立性转移性疾病患者获得长期生存。